Norway· NO-ID_6DD26FF3-A309-43E1-A765-553662C7ECA4

Granisetron-ratiopharm

A granisetron product containing granisetron, registered in Norway by Ratiopharm. The same ATC class is registered in 18 of our 19 countries.

ATC A04AA02

Checked against FEST (Norway) on September 25, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about granisetronAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Granisetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA02 (granisetron), each read from that country’s own register.

This record: Norway, from FEST (Norway)
10 of them publish a price we can compare per daily dose

Search granisetron products by name

Granisetron · ATC A04AA02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of granisetron costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $10.02 in Italy to $29.01 in Switzerland — a ×2.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Granisetron · price per daily dose (2 mg)

USD · FX 28 Sept 2026

CH Switzerland$29.01
FR France$11.60
IT Italy$10.02

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)

Active substance: Granisetron
Manufacturer: Ratiopharm
Country: Norway (NO)
ATC code: A04AA02
ATC class: Granisetron
Defined daily dose: 2 mg, O
Reimbursed: Not published by this register
Source register: FEST (Norway)
Last checked: September 25, 2026

Packs & prices · 3

no_merkevare_id
ID_6DD26FF3-A309-43E1-A765-553662C7ECA4
no_varenummer
346424
5
gtin
4150066075071

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

564 interactions on record for granisetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check granisetron against other medicines How interaction checks work

Granisetron · interactions on record

564 records

139 severe
244 moderate
9 minor
172 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
FenfluramineA08AA02severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Granisetron in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All granisetron products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Granisetron Actavis, Kytril
Belgium · Granisetron Fresenius Kabi, Kytril
Bulgaria · Расетрон
Czechia · Granegis, Granisetron Kabi
Germany · Grani, Granisetron Baxter
Denmark · Granisetron Hameln, Granisetron Stada
Estonia · Kytril
Spain · Granisetrón Altan, Granisetrón Aurovitas Spain
Finland · Gazoron, Granisetron Baxter
France · Kytril
United Kingdom (Northern Ireland) · Granisetron, Granisetron Dawa
Greece · Granitron, Viatrinil 1mg/Ml
Croatia · Granizetron Kabi
Hungary · Granegis, Granigen
Ireland · Kytril
Iceland · Grandise, Granem
Italy · Grandise, Granem
Liechtenstein · Sancuso
Malta · Granisetron Sigillata
Netherlands · Granisetron Baxter, Granisetron Fresenius Kabi
Portugal · Granisetron Orchid Europe, Granissetrom Aurovitas
Romania · Granisetron Kabi, Granisetron Labormed
Sweden · Granisetron Fresenius Kabi, Granisetron Hameln
Slovenia · Granisetron Lek, Kytril
Slovakia · Emegar, Granegis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/82389f40-0998-449f-bd1c-ded78f61d2c8
GET /v1/drugs/82389f40-0998-449f-bd1c-ded78f61d2c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Granisetron",
  "merkevare_id": "ID_6DD26FF3-A309-43E1-A765-553662C7ECA4",
  "name_form_strength": "Granisetron-ratiopharm tab 2 mg",
  "prescription_group": "C"
}

API reference MCP server Plans

See everything about granisetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console